EDENIL SOLUZ VAG 5FL 100ML0,1G

EDENIL

active ingredients

EDENIL 0.1 g vaginal solution 100 ml contain: Active ingredient: Ibuprofen isobutanolammonium 0.1 g. EDENIL 1 g powder for vaginal solution A envelope contains: Active ingredient: Ibuprofene isobutanolammonio 1 g. For the complete list of excipients, see paragraph 6.1

Excellent

Edenil 0.1 g vaginal solution: 2-phenoxethanol, methyl phydroxybenzoate (E218), ethyl p-hydroxybenzoate (E214), propyl p-hydroxybenzoate (E216), butyl p-hydroxybenzoate, polysorbate 20, propylene glycol, floral essence, purified water. Edenil 1 g powder for vaginal solution: Imidazolidinilurea, sodium chloride.

Therapeutic indications

Edenil is indicated for the treatment of symptoms of vulvovaginitis characterized by small vaginal losses, itching, irritation, burning and vulvary pain.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients. Hypersensitivity to substances closely related to ibuprofen.

Population

1 or 2 vaginal irrigations per day, using the bottle containing the substance ready for use or melting the content of 1-2 envelopes in 1 liter of water for each vaginal irrigation. The vaginal solution ready for use can be used at room temperature or warm by placing the bottle under a hot water flow. 1. Eliminate, pushing sideways, the seal of guarantee and closure. 2. Extract the cannula from the protective casing, grafting it on the bottle, to ensure its stable positioning. 3. To prepare in such a way that the solution can carry out its detersion and therapy action (by joining or sitting on toilets). 4. The cannula ends with an apical dispenser that has 3 holes for irrigation and 3 grooves for the discharge of the liquid. 5. Gently introduce in the vagina only the apical dispenser until the insertion limit. 6. Compress the bottle until completely emptying. Keep the liquid in the vagina for a few minutes to allow the solution to carry out its therapeutic action. Follow the instructions of the doctor.

Conservation

No special education. Store Edenil 0.1 g vaginal solution at temperature not exceeding 30°C.

Warnings

Edenil should not be used in specific or non-specific severe vulvovaginitis. The use, especially if prolonged, of products for topical use can give rise to phenomena of hypersensitivity. In this case it is necessary to stop treatment and establish suitable therapy. The vaginal solution contains p-hydroxybenzoates that can cause allergic reactions (also delayed) and propylene glycol that can cause skin irritation. In case of non-response within 3 days from the beginning of administration, avoid persisting in treatment and consult your doctor.

Interactions

There are no interactions with other medicines.

Effects

From post-marketing experience, irritation was reported in the application, erythema, hives, itching and reaction from drug with heosinophilia and systemic symptoms ( DRESS syndrome) with unknown frequency (frequency cannot be defined on the basis of the available data). Photosensitivity reactions - frequency not known. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversa.

Overdosing

In cases of severe poisoning, it is possible that metabolic acidosis occurs.

We do not recommend use during pregnancy and nursing.

Source: Farmadati